Skip to main content
. Author manuscript; available in PMC: 2011 Jan 11.
Published in final edited form as: Exp Brain Res. 2008 Dec 2;193(4):555–563. doi: 10.1007/s00221-008-1658-4

Table 2.

Subject characteristics at T2 (after drug ingestion) where all % values represent % maximum stimulator output unless stated otherwise. Values represent means ± standard deviation.

Drug arm RMT AMT Sensory
threshold
SICI/ICF LICI SAI
TS
Intensity
TS
Amplitude
TS
Intensity
TS
Amplitude
TS
Intensity
TS
Amplitude
Lorazepam 40.6
± 6.3 %
30.4
± 4.4 %
0.20
± 0.03 mA
52.1
± 8.6 %
0.66
± 0.38 mV
53.3
± 8.5 %
0.76
± 0.68 mV
52.6
± 8.7 %
0.52
± 0.29 mV
Zolpidem 39.9
± 5.6 %
30.1
± 5.5 %
0.17
± 0.04 mA
50.5
± 7.9 %
0.78
± 0.29 mV
51.0
± 8.4 %
0.73
± 0.27 mV
50.6
± 8.3 %
0.71
± 0.31 mV